Home › Funds › DC Funds, LP › TCRX
DC Funds, LP position in TCRX
TSCAN THERAPEUTICS INC · Health Care
DC Funds, LP reported holding 630,000 shares of TCRX (TSCAN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$198.1M, representing 26.72% of its reported portfolio and ranking #2 among its reported holdings. DC Funds, LP has disclosed TCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How DC Funds, LP's TCRX position evolved
DC Funds, LP first disclosed a stake in TCRX in Q3 2023 at 630,000 shares (US$1.6M). The position peaked in Q1 2025 at 630,000 shares, worth US$869.4M. Across 13 filings, DC Funds, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 630,000 shares valued at US$198.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 630.00K | $1.61M | New |
| Q4 2023 | 630.00K | $3.67M | Hold |
| Q1 2024 | 630.00K | $5.00M | Hold |
| Q2 2024 | 630.00K | $3.69M | Hold |
| Q3 2024 | 630.00K | $3.14M | Hold |
| Q4 2024 | 630.00K | $1.92M | Hold |
| Q1 2025 | 630.00K | $869.40M | Hold |
| Q2 2025 | 630.00K | $913.50K | Hold |
| Q3 2025 | 630.00K | $1.15M | Hold |
| Q4 2025 | 630.00K | $630.00M | Hold |
| Q1 2026 | 630.00K | $630.00M | Hold |
| Q2 2026 | 630.00K | $617.46M | Hold |
| Q3 2026 | 630.00K | $198.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TCRX and 13F data
TCRX (TSCAN THERAPEUTICS INC) is a Health Care company. 20 other funds we track also report a position in TCRX — the largest reported positions include Lynx1 Capital Management LP (US$7.9M), BVF INC/IL (US$5.5M), Deer Management Co. LLC (US$1.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TCRX
- Lynx1 Capital Management LP 8.02M sh · $7.86M · Q2 2026
- BVF INC/IL 5.56M sh · $5.45M · Q2 2026
- Deer Management Co. LLC 1.25M sh · $1.22M · Q2 2026
More on DC Funds, LP
FAQ
How long has DC Funds, LP held TCRX?
DC Funds, LP has disclosed TCRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is DC Funds, LP's current position in TCRX?
As of Q3 2026, DC Funds, LP holds 630.00K shares of TCRX (TSCAN THERAPEUTICS INC), valued at $198.13M, representing 26.72% of its reported portfolio and ranking #2.
Has DC Funds, LP been buying or selling TCRX?
In the latest 13F filing (Q3 2026), DC Funds, LP held unchanged its position in TCRX. The position peaked in Q1 2025 at 630.00K shares.
Which other funds hold TCRX?
Other major institutional holders of TCRX include Lynx1 Capital Management LP, BVF INC/IL, Deer Management Co. LLC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.